INNOVATE Corp. to Report Third Quarter 2025 Results on November 12th | VATE Stock NewsStockTitan·Oct 22, 2025 at 08:05 PMVATE RTVATE-3.94%
MediBeacon receives regulatory approval to sell the Transdermal GFR System in ChinaGlobeNewswire·Oct 21, 2025 at 01:03 PMVATE RTVATE-3.94%
INNOVATE’s Portfolio Company DBM Global to Pay Cash Dividend | VATE Stock NewsStockTitan·Oct 16, 2025 at 08:15 PMVATE RTVATE-3.94%
Tongxin Medical's BrioVAD has received FDA approval to enter the confirmatory phase of clinical researchZhitong·Aug 7, 2025 at 02:28 AMVATE RTVATE-3.94%
INNOVATE Closes Indebtedness Refinancing TransactionsGlobeNewswire·Aug 4, 2025 at 09:34 PMVATE-3.94%VATE RT